These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8126405)

  • 1. Cost-effectiveness analysis of screening health care workers for HIV.
    Chavey WE; Cantor SB; Clover RD; Reinarz JA; Spann SJ
    J Fam Pract; 1994 Mar; 38(3):249-57. PubMed ID: 8126405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for human immunodeficiency virus in physicians. Who should we test and what will it cost.
    Levine AA; Sandler RS
    N C Med J; 1994 Apr; 55(4):136-40. PubMed ID: 8008080
    [No Abstract]   [Full Text] [Related]  

  • 3. Who should be screened for HIV infection? A cost-effectiveness analysis.
    McCarthy BD; Wong JB; Muñoz A; Sonnenberg FA
    Arch Intern Med; 1993 May; 153(9):1107-16. PubMed ID: 8481077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of HIV screening of blood donations in Accra (Ghana).
    van Hulst M; Sagoe KW; Vermande JE; van der Schaaf IP; van der Tuuk Adriani WP; Torpey K; Ansah J; Mingle JA; Smit Sibinga CT; Postma MJ
    Value Health; 2008; 11(5):809-19. PubMed ID: 18489518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal precautions to prevent HIV transmission to health care workers: an economic analysis.
    Stock SR; Gafni A; Bloch RF
    CMAJ; 1990 May; 142(9):937-46. PubMed ID: 2158390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.
    Gorsky RD; Farnham PG; Straus WL; Caldwell B; Holtgrave DR; Simonds RJ; Rogers MF; Guinan ME
    Public Health Rep; 1996; 111(4):335-41. PubMed ID: 8711101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis.
    Doyle NM; Levison JE; Gardner MO
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1280-5. PubMed ID: 16157152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
    Mrus JM; Tsevat J
    Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness estimates for antenatal HIV testing in the Netherlands.
    Rozenbaum MH; Verweel G; Folkerts DK; Dronkers F; van den Hoek JA; Hartwig NG; de Groot R; Postma MJ
    Int J STD AIDS; 2008 Oct; 19(10):668-75. PubMed ID: 18824618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department.
    Dowdy DW; Rodriguez RM; Hare CB; Kaplan B
    Acad Emerg Med; 2011 Jul; 18(7):745-53. PubMed ID: 21762236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental cost-effectiveness of two zidovudine regimens to prevent perinatal HIV transmission in the United States.
    Pinkerton SD; Holtgrave DR; Layde PM
    Prev Med; 2000 Jan; 30(1):64-9. PubMed ID: 10642461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of HIV screening in acute care settings.
    Owens DK; Nease RF; Harris RA
    Arch Intern Med; 1996 Feb; 156(4):394-404. PubMed ID: 8607724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Web interface-supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands.
    van Hulst M; Hubben GA; Sagoe KW; Promwong C; Permpikul P; Fongsatitkul L; Glynn DM; Sibinga CT; Postma MJ
    Transfusion; 2009 Dec; 49(12):2729-42. PubMed ID: 19709093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness.
    Holtgrave DR
    J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine prenatal screening for HIV in a low-prevalence setting.
    Patrick DM; Money DM; Forbes J; Dobson SR; Rekart ML; Cook DA; Middleton PJ; Burdge DR
    CMAJ; 1998 Oct; 159(8):942-7. PubMed ID: 9834719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupational exposure to the risk of HIV infection among health care workers in Mwanza Region, United Republic of Tanzania.
    Gumodoka B; Favot I; Berege ZA; Dolmans WM
    Bull World Health Organ; 1997; 75(2):133-40. PubMed ID: 9185365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An economic evaluation of mandatory premarital testing for HIV.
    McKay NL; Phillips KM
    Inquiry; 1991; 28(3):236-48. PubMed ID: 1833334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.
    Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO
    Arch Intern Med; 2004 Jan; 164(1):46-54. PubMed ID: 14718321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The costs and benefits of enhanced depression care to employers.
    Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
    Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.